Anami Y. et al. 2020. Molecular Cancer Therapeutics. 19(11):2330-2339
LILRB4-targeting Antibody–Drug Conjugates for the Treatment of Acute Myeloid Leukemia
Previous
Previous
Preclinical characterization of a novel therapeutic antibody targeting LILRB2
Next
Next

